Deutsche Bank’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Deutsche Bank’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-10,158	Closed	-$13K	–	5522
2016 Q2	$13K	Buy	+10,158	New	+$16.3K	﹤0.01%	4871
2016 Q1	–	Sell	-299	Closed	–	–	5500
2015 Q4	$0	Buy	+299	New	+$480	﹤0.01%	5532
2014 Q4	–	Sell	-245	Closed	–	–	6490
2014 Q3	$0	Buy	+245	New	+$441	﹤0.01%	6279
2013 Q3	–	Sell	-74	Closed	–	–	5885
2013 Q2	$0	Buy	+74	New	+$388	﹤0.01%	5385

Other funds holding ECTE

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Deutsche Bank's ECTE Position: Q3 2016 in Review

Deutsche Bank sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2016, closing a stake of 10,158 shares — an estimated $13K sold.

Deutsche Bank first reported a position in ECTE in Q2 2013 and held it in 4 quarters. The position peaked at $13K in Q2 2016. 2 funds tracked by Wall St. Rank hold ECTE as of Q3 2016.

Deutsche Bank reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2016 after selling out during the quarter.
Deutsche Bank sold 10,158 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2016, an estimated $13K.
Deutsche Bank first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 4 quarters.
Deutsche Bank's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $13K in Q2 2016.
2 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2016.

Based on Deutsche Bank's 13F filing for Q3 2016, filed 14 Nov 2016.